Close
Nordic 9Nordic 9

Omega Funds (investor - Private Equity)

United States omegafunds.net
See something wrong or missing? Let us know
Offices:Boston

Omega Funds is an American investment firm that creates and invests in life sciences companies that target the world’s most urgent medical needs.

Average round investment:65.13M USD
Average number per year:2.1
Distribution: 2025 (4)2024 (1)2023 (3)2022 (3)2021 (1) See the entire list
Portfolio companies: United Kingdom Artios PharmaUnited Kingdom NRG TherapeuticsNorway Artbio See the entire list
Mostly invests in: United Kingdom United Kingdom (4) Health services (15)
See the entire list

Showing 3 of 15 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Omega Funds mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Omega Funds

Name Criteria
United States Sands Capital Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Germany
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
United States Polaris Partners
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Switzerland, Denmark, Germany
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States SR One
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Denmark
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Spain Ysios Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Switzerland, Denmark, Spain
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Germany Burda Principal Investments
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Denmark, Germany, Spain
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Hong Kong Horizons Ventures
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Belgium, Germany
  • Average number of deals per year: 3.1
  • Active last 12 months: Yes
Switzerland Pureos Bioventures
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Switzerland, Denmark, Germany
  • Average number of deals per year: 3.6
  • Active last 12 months: Yes
Netherlands Prosus Ventures
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Norway, Switzerland, Denmark, Germany, Spain
  • Average number of deals per year: 3.8
  • Active last 12 months: Yes
Israel Canaan Partners
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Pharma, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Belgium, Denmark, Germany
  • Average number of deals per year: 4.0
  • Active last 12 months: Yes
United States Koch Disruptive Technologies
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 4.0
  • Active last 12 months: Yes
Top